We have developed a new system for the production of autologous platelet-rich plasma and red blood cell concentrates to be used in autologous transfusion support of cardiac surgery patients. In 15 operations no homologous blood products were required. Costs were diminished since with the same harness it was possible to carry out the intraoperative blood salvage and concentrate the erythrocytes contained in the oxygenator and its lines. Indirect costs were also reduced since no infective complication was observed due to homologous blood products.
MannM., SacksH.J., GoldfingerD.Safety of autologous blood donation prior to elective surgery for a variety of potentially “high-risk” patients.Transfusion1983; 23: 229–32.
BrewsterD.C.Intraoperative autotransfusion in major vascular surgery.Am J Surg1979; 137: 507–13.
4.
DueT.L.Intraoperative autotransfusion in the management of massive hemorrhage.Am J Surg1975; 130: 653–58.
5.
TremoladaF., ChiappettaP., NoventaF., ValfréC., OngaroG., RealdiG.Prospective study of post-transfusion hepatitis in cardiac surgery patients receiving only blood or also blood products.Vox Sang1983; 44: 25–30.
6.
RzadL., MurphyS., BucholzD.H., DavissonW., GajewskiM., AsterR.H.Storage of platelet concentrates for seven days in PL 732™ plastic.Transfusion1982; 22: 417 (abstract).
7.
MelaragnoA.J., CarcieroR., FeingoldH., TalaricoL., WeintraubL., ValeriC.R.Cryopreservation of human platelets using 6% dimethyl sulfoxide and storage at -80°C.Effects of 2 years of frozen storage at -80°C and transportation in dry ice. Vox Sang1985; 49: 245–58.
